Tenet Reports Results for the Third Quarter Ended September 30, 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Tenet Healthcare (THC) PT Raised to $33 at Mizuho Securities
November 5, 2019 11:59 AM ESTMizuho Securities analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $33.00 (from $30.00) while maintaining a Buy rating.
The analyst commented, "We are raising our price target on THC to $33 (from $30) post a solid 3Q:19. Volume growth accelerated... More
Tenet Healthcare (THC) Tops Q3 EPS by 28c, Offers Q4 Guidance
November 4, 2019 4:21 PM ESTTenet Healthcare (NYSE: THC) reported Q3 EPS of $0.58, $0.28 better than the analyst estimate of $0.30. Revenue for the quarter came in at $4.57 billion versus the consensus estimate of $4.46 billion.
GUIDANCE:
Tenet Healthcare sees Q4 2019 EPS of $0.57-$1.23, versus the consensus of $1.00.... More



